Back to search
FDAFDA · Food and drugs·Recall number D-0394-2026

Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.

Published March 11, 2026 · Recall initiated: February 26, 2026

Summary

FDA records drug Class II recall D-0394-2026, published March 11, 2026 and initiated February 26, 2026. Recalling firm: New Life Pharma LLC; Status: Ongoing; Reported quantity: 23 vials; Lot: Lot 240709, exp 7/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
New Life Pharma LLC
Distributor
OH
Lot
Lot 240709, exp 7/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03. recalled?

Yes. FDA published recall D-0394-2026 on March 11, 2026. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter